Home » Stocks » SOLY

Soliton, Inc. (SOLY)

Stock Price: $18.00 USD 0.62 (3.57%)
Updated May 7, 2021 4:00 PM EDT - Market closed
After-hours: $17.90 -0.10 (-0.56%) May 7, 4:14 PM
Market Cap 384.46M
Revenue (ttm) n/a
Net Income (ttm) -14.54M
Shares Out 21.36M
EPS (ttm) -0.77
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 7
Last Price $18.00
Previous Close $17.38
Change ($) 0.62
Change (%) 3.57%
Day's Open 17.18
Day's Range 17.18 - 18.31
Day's Volume 123,837
52-Week Range 5.69 - 19.65

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

HOUSTON, May 5, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the ...

2 days ago - PRNewsWire

HOUSTON, May 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Compa...

3 days ago - PRNewsWire

HOUSTON, April 29, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the U.S. Fo...

1 week ago - PRNewsWire

HOUSTON, April 27, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the 52...

1 week ago - PRNewsWire

HOUSTON, April 15, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the U....

3 weeks ago - PRNewsWire

HOUSTON, March 11, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced members of ...

1 month ago - PRNewsWire

HOUSTON, March 9, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced th...

1 month ago - PRNewsWire

HOUSTON, March 4, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial res...

2 months ago - PRNewsWire

HOUSTON, Feb. 22, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the Com...

2 months ago - PRNewsWire

HOUSTON, Feb. 18, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that the com...

2 months ago - PRNewsWire

HOUSTON, Feb. 1, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced tha...

3 months ago - PRNewsWire

HOUSTON, Jan. 26, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced it has enter...

3 months ago - PRNewsWire

HOUSTON, Dec. 30, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the appointm...

4 months ago - PRNewsWire

Soliton, Inc. (SOLY) CEO Brad Hauser on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

HOUSTON, Nov. 12, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial res...

5 months ago - PRNewsWire

HOUSTON, Nov. 2, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the...

6 months ago - PRNewsWire

HOUSTON, Oct. 27, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced it...

6 months ago - PRNewsWire

HOUSTON, Oct. 5, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced the...

7 months ago - PRNewsWire

HOUSTON, Sept. 8, 2020 /PRNewswire/ -- Soliton, Inc.

7 months ago - PRNewsWire

HOUSTON, Aug. 26, 2020 /PRNewswire/ -- Soliton, Inc.

8 months ago - PRNewsWire

HOUSTON, Aug. 20, 2020 /PRNewswire/ -- Soliton, Inc.

8 months ago - PRNewsWire

HOUSTON, Aug. 13, 2020 /PRNewswire/ -- Soliton, Inc.

8 months ago - PRNewsWire

Soliton, Inc.'s (SOLY) CEO Chris Capelli on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

HOUSTON, Aug. 11, 2020 /PRNewswire/ -- Soliton, Inc.

8 months ago - PRNewsWire

HOUSTON, Aug. 5, 2020 /PRNewswire/ -- Soliton, Inc.

9 months ago - PRNewsWire

HOUSTON, July 29, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, announced today that it will...

9 months ago - PRNewsWire

HOUSTON, July 22, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced Dr.

9 months ago - PRNewsWire

Soliton (SOLY) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

9 months ago - Zacks Investment Research

Stock is down nearly 50% in the last few weeks, as a massive share offering well below where the stock was trading sparked selling.

10 months ago - Seeking Alpha

HOUSTON, June 26, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced the pricing ...

10 months ago - PRNewsWire

HOUSTON, June 25, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today announced that it inte...

10 months ago - PRNewsWire

Soliton (SOLY) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.

10 months ago - Zacks Investment Research

Soliton's (SOLY) CEO Chris Capelli on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

HOUSTON, May 14, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology, today reported financial resu...

11 months ago - PRNewsWire

Soliton: A Solid Play On The Tattoo Removal Opportunity In 2020

1 year ago - Seeking Alpha

These 5 stocks all have a real chance of winding up at zero — but if they can avoid that outcome, they could easily triple or more.

Other stocks mentioned: ACB, CHK, GCI, RAD
1 year ago - InvestorPlace

Soliton is developing a breakthrough technology for tattoo removal and cellulite treatment which will save time and money and have a higher degree of efficiency.

1 year ago - Seeking Alpha

The roller coaster ride continues.

1 year ago - The Motley Fool

Medical device company Soliton Inc. (NASDAQ: SOLY) shares are trading higher again after the company highlighted its preclinical results for its new RAP device, which "is a potentially important new way...

1 year ago - Benzinga

The company is riding high following FDA clearance for its tattoo removal medical device.

1 year ago - The Motley Fool

Medical device company Soliton Inc. shares are trading higher again after the company announced its decision to move forward with a pivotal trial after positive data from its proof-of-concept trial to r...

1 year ago - Benzinga

Approval from the U.S. Food and Drug Administration (FDA) for a Soliton tattoo removal device has SOLY stock on the rise Wednesday.

1 year ago - InvestorPlace

Medical device company Soliton Inc. has received FDA 510(k) approval for its acoustic wave device for dermal tattoo clearing.

1 year ago - Benzinga

There is no guarantee Soliton’s RAP technology will be able to penetrate the tattoo removal market.

2 years ago - Seeking Alpha

About SOLY

Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas.

Industry
Medical Devices
IPO Date
Feb 19, 2019
Stock Exchange
NASDAQ
Ticker Symbol
SOLY
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

According to 3 analysts, the average rating for Soliton stock is "Buy." The 12-month stock price forecast is 23.00, which is an increase of 27.78% from the latest price.

Price Target
$23.00
(27.78% upside)
Analyst Consensus: Buy